Maravai Lifesciences Holdings (MRVI) FCF Payout Ratio (2020 - 2024)

Maravai Lifesciences Holdings' FCF Payout Ratio history runs 5 years deep, the most recent figure standing at 0.01 for Q4 2024.

• On a quarterly basis, FCF Payout Ratio changed N/A year-over-year to 0.01 in Q4 2024; TTM through Sep 2025 was 0.02, a 256.43% decrease from a year earlier, with the FY2024 full-year figure at 0.1, up 31.72% from the prior year.
• FCF Payout Ratio declined to 0.01 in Q4 2024 per MRVI's latest filing, from 0.11 in the prior quarter.
• Across five years, FCF Payout Ratio topped out at 1.7 in Q4 2020 and bottomed at 0.22 in Q2 2023.
• The 5-year median for FCF Payout Ratio is 0.25 (2022), against an average of 0.39.
• Across the five-year window, FCF Payout Ratio soared 15966.18% in 2021 and slumped 184.44% in 2023, its largest moves.
• Year by year, FCF Payout Ratio stood at 1.7 in 2020, then fell by 1.4% to 1.67 in 2021, then plunged by 82.96% to 0.28 in 2022, then sank by 178.09% to 0.22 in 2023, then jumped by 94.65% to 0.01 in 2024.
• Per Business Quant, the three latest MRVI FCF Payout Ratio figures stand at 0.01 (Q4 2024), 0.11 (Q2 2024), and 0.22 (Q2 2023).